RIRS
About RIRS
RIRS (Retrograde Intrarenal Surgery) is an established minimally invasive urology technique using flexible ureteroscopy and laser stone fragmentation to treat kidney stones, with continued adoption and refinement in endourology.
Trend Decomposition
Trigger: Rising prevalence of kidney stones and demand for minimally invasive, organ sparing treatment options.
Behavior change: Surgeons increasingly perform RIRS as first line or preferred approach for medium to large renal stones when feasible, and clinics invest in flexible ureteroscopes and laser systems.
Enabler: Advances in flexible ureteroscopes, efficient stone fragmentation lasers (e.g., holmium
Constraint removed: Reduced need for percutaneous access in certain stones and shorter recovery compared to open or percutaneous approaches.
PESTLE Analysis
Political: Regulatory approvals and reimbursement policies influence adoption; training standards shape credentialing in endourology.
Economic: Capital investment in endourology equipment and cost per procedure considerations drive adoption in high volume centers.
Social: Patient demand for minimally invasive options and faster return to daily life increases acceptance of RIRS.
Technological: Improvements in flexible ureteroscopes, superior laser lithotripsy, and digital imaging enhance safety and effectiveness.
Legal: Standardization of procedural guidelines and informed consent practices mitigate malpractice risk in endourology.
Environmental: Reprocessing and sterilization of reusable scopes raise sustainability considerations; single use accessories are debated for cost and waste.
Jobs to be done framework
What problem does this trend help solve?
Provide effective, minimally invasive kidney stone treatment with rapid recovery.What workaround existed before?
Open or percutaneous nephrolithotomy; non surgical stone passage with lower success rates.What outcome matters most?
Safety balanced with stone free rate, reduced hospital stay, and faster return to normal activities.Consumer Trend canvas
Basic Need: Safe, minimally invasive stone management with rapid recovery.
Drivers of Change: Technological advances in flexible endoscopy and lasers; patient preference for less invasive care.
Emerging Consumer Needs: Clearer diagnostic pathways, shorter anesthesia exposure, and higher stone free expectations.
New Consumer Expectations: Visible results, reduced retreatment, and access to high volume endourology centers.
Inspirations / Signals: Published outcomes comparing RIRS to alternatives; guideline endorsements for stone disease management.
Innovations Emerging: Robotic assisted flexible ureteroscopy, improved irrigation dynamics, and real time stone tracking.
Companies to watch
- Olympus Corporation - Manufacturer of flexible ureteroscopes and endourology visualization systems used in RIRS.
- Karl Storz SE & Co. KG - Produces endoscopic equipment including ureteroscopes and laser systems used in RIRS.
- Richard Wolf GmbH - Endoscopy company offering ureteroscopes and accessories for RIRS procedures.
- Boston Scientific - Supplies endourology tools and laser related technologies used in stone management.
- Lumenis - Laser technology provider for lithotripsy and stone fragmentation in RIRS.
- Quanta System - Offers holmium laser systems and accessories suitable for RIRS lithotripsy.
- Coloplast - Provides endourology related consumables and access products supporting RIRS workflows.
- ConMed - Endourology instruments and accessories used in ureteroscopy procedures.
- Cook Medical - Manufacturer of ureteral access sheaths and related endourology equipment for RIRS.
- Porgès Medical - Provider of endoscopic tools and kits for urologic stone management.